About VieCure
VieCure is a Healthcare company based in Greenwood Village (United States) founded in 2015 by Fred Ashbury. Oncology treatment plans are generated via an AI-based platform. VieCure has raised $113 million across 3 funding rounds from investors including Northpond Ventures, Durable Capital Partners and Socium Ventures. VieCure offers products and services including VieCure Platform and Halo Intelligence Platform. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include Syapse, BostonGene and Kuveda; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2015 and based in Greenwood Village, United States, VieCure operates in the oncology sector through an AI platform. Patient-specific treatment plans are created for oncologists, supported by an electronic medical record system that tracks medical history, treatment progress, notes, prescriptions, medication administration, scheduling, and pharmacy services. A mobile application is provided for patient engagement, including treatment adherence, side effect monitoring, and communication with the oncology team.
- Total Equity Funding$113M (USD)
in 3 rounds
- Latest Funding Round$43M (USD), Series C
Jan 2026
- InvestorsNorthpond Ventures
& 3 more
Products & Services of VieCure
VieCure offers a comprehensive portfolio of products and services, including VieCure Platform and Halo Intelligence Platform.
Platform for personalizing cancer care with AI tools.
System for advanced cancer care insights and data processing.
Apps and channels of VieCure
its YouTube channel VieCure has 10 subscribers and 2 videos.
Videos from VieCure
The most watched videos on VieCure's YouTube channel, VieCure (10 subscribers). Click a video to play it here.
More on VieCure.
Funding Insights of VieCure
VieCure has successfully raised a total of $113M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $43 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $113M
- Total Rounds 3
- Last Round Series C — $43M
- First Round $25M
(Apr 2021)
- Investors Count 4
All 3 funding rounds of VieCure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $43M | Series C | – | – | |
| Oct 2024 | $45M | Series B | – | Northpond Ventures | – |
| Apr 2021 | $25M | Series A | – | Northpond Ventures | – |
4 investors in total: 4 institutional.
Investors in VieCure
VieCure has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Northpond Ventures, Durable Capital Partners and Socium Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
| durablecap.com | ||||
| sociumventures.com | ||||
| satorgrove.com |
Investor details for VieCure
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VieCure
34 people are tracked at VieCure (14 in leadership, 20 in team).
| Name | Role | Group |
|---|---|---|
Fred Ashbury | Co-Founder | Leadership |
Brian R. Leyland-Jones - MBBS, PhD, B.Sc, LRCP, MCRS, ECFMG | Co-Founder | Leadership |
Michael Power | Chief Executive Officer | Leadership |
Rachel White | VP, Marketing & Brand | Leadership |
Tony Romano | Vice President & General Manager | Leadership |
Sam Wheeler | Director Of Business Development Strategic Accounts | Leadership |
Rob Gibson | Chief Technology Officer | Leadership |
Sean McCarthy | Chief Technology Officer | Leadership |
Adam Seltser | Chief Financial Officer | Leadership |
Keith Thompson, M.D. | Medical Director | Leadership |
Jim Lardner | Director, Product Operations & Quality Engineering | Leadership |
Fred Ashbury PhD MACE | Chief Scientific Officer | Leadership |
Heath McMillion | Vice President, Product Development | Leadership |
Jake Thomas | Director Of Business Development - Strategic Accounts | Leadership |
Serge Skop | Senior Software Engineer | Team |
Niki McFarland | Senior Product Owner (ai Initiatives) | Team |
Chris Prechtl | Principal Consultant, Client Services | Team |
Kara Oberik | Software Engineer | Team |
Peyton Birch | Customer Success Manager | Team |
Benjamin Jacobs | Software Engineer | Team |
14 more people are available in the full profile.
Complete people profiles for VieCure
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VieCure
3 dated milestones of VieCure across 11 years, from founding to its latest funding, stage changes and deals.
- Founded VieCure is founded.
- Funding First funding round of $25.0M.
- Funding Latest funding round, Series C, of $43.0M.
Competitors of VieCure
VieCure has 3 listed competitors in our database, 3 of them funded. They include Syapse, BostonGene and Kuveda.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| syapse.com | 2008 | San Francisco, United States | $221.1M | 209 | Developer of precision medicine for the treatment of cancer | |
| bostongene.com | 2015 | Waltham, United States | $200M | 46 | Developer of cloud-based information and analytics platform to treat cancer | |
| kuveda.com | 2013 | San Jose, United States | $70,000 | SaaS tools for analyzing cancer patients' molecular profiles are provided. |
Detailed competitors of VieCure
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of VieCure
The website of VieCure (viecure.com) receives about 6.6K visits a month.
- Monthly visits6.6K
▼ 17.3% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as VieCure (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Viecure
Complete news archive for VieCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VieCure
VieCure was founded in 2015 and raised its 1st funding round 6 years after it was founded.
VieCure is headquartered in Greenwood Village, United States. It is registered at Greenwood Village, Colorado, United States.
VieCure is a funded company, having raised a total of $113M across 3 funding rounds to date. The company's 1st funding round was a Series A of $25M, raised on Apr 2021.
Founded in 2015 and based in Greenwood Village, United States, VieCure operates in the oncology sector through an AI platform. Patient-specific treatment plans are created for oncologists, supported by an electronic medical record system that tracks medical history, treatment progress, notes, prescriptions, medication administration, scheduling, and pharmacy services. A mobile application is provided for patient engagement, including treatment adherence, side effect monitoring, and communication with the oncology team.
VieCure's top competitors include Syapse, BostonGene and Kuveda.
VieCure offers VieCure Platform and Halo Intelligence Platform.
VieCure has 4 investors. Key investors include Northpond Ventures, Durable Capital Partners, Socium Ventures, and Sator Grove Holdings.